Ambeed.cn

首页 / 抑制剂/激动剂 / 蛋白质酪氨酸激酶 / IGF-1R / GSK1904529A

GSK1904529A {[allProObj[0].p_purity_real_show]}

货号:A417175 同义名: GSK 4529

GSK1904529A is a selective inhibitor of IGF-1R and IR with IC50 of 27 nM and 25 nM, being > 100-fold selective for IGF-1R/InsR than Akt1/2, Aurora A/B,B-Raf, CDK2, EGFR etc.

GSK1904529A 化学结构 CAS号:1089283-49-7
GSK1904529A 化学结构
CAS号:1089283-49-7
GSK1904529A 3D分子结构
CAS号:1089283-49-7
GSK1904529A 化学结构 CAS号:1089283-49-7
GSK1904529A 3D分子结构 CAS号:1089283-49-7
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 咨询 - +
购物车0 收藏 询单

GSK1904529A 纯度/质量文件 产品仅供科研

货号:A417175 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nat. Biomed. Eng., 2024, 8, 1412-1424. Ambeed. [ A538667 , A631746 ]
JMC, 2024. Ambeed. [ A833302 , A475501 , A341986 , A356070 ]
BMC Cancer, 2024, 24(1): 1415. Ambeed. [ A809692 , A209020 ]
J. Am. Soc. Mass Spectrom., 2024, 35(12): 3192-3202. Ambeed. [ A166127 , A902473 , A753371 , A961334 , A292945 , A230770 , A300620 , A1114580 , A1159765 , A206238 ]
PloS One, 2024, 19(11): e0308060. Ambeed. [ A302917 ]
更多 >
产品名称 IGF-1R Insulin Receptor 其他靶点 纯度
BMS-536924 ++

IGF-1R, IC50: 100 nM

+++

Insulin Receptor, IC50: 73 nM

MEK,FAK 98%
GSK1904529A +++

IGF-1R, IC50: 27 nM

+++

Insulin Receptor, IC50: 25 nM

98+%
Picropodophyllin ++++

IGF-1R, IC50: 1 nM

99%+
NVP-AEW541 ++

IGF-1R, IC50: 0.15 μM

++

Insulin Receptor, IC50: 0.14 μM

FLT3 99%+
NVP-ADW742 +

IGF-1R, IC50: 0.17 μM

99%
GSK1838705A +++

IGF-1R, IC50: 2 nM

++++

Insulin Receptor, IC50: 1.6 nM

ALK 99%
BMS-754807 ++++

IGF-1R, IC50: 1.8 nM

++++

Insulin Receptor, IC50: 1.7 nM

99%+
Linsitinib +++

IGF-1R, IC50: 35 nM

++

Insulin Receptor, IC50: 75 nM

99%+
AG1024 +

IGF-1R, IC50: 7 μM

+

Insulin Receptor, IC50: 57 μM

98%
PQ401 +

IGF-1R, IC50: <1 μM

99%+
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

GSK1904529A 生物活性

靶点
  • IGF-1R

    IGF-1R, IC50:27 nM

  • Insulin Receptor

    Insulin Receptor, IC50:25 nM

描述 IGF-1R (insulin-like growth factor-1 receptor) plays a key role in transformation, growth and survival of malignant cells, and has been considered as a general and promising target for cancer treatment. GSK1904529A is a selective inhibitor of IGF-IR and IR with IC50 values of 27 and 25nM, respectively. Treatment with GSK1904529A ranging in 0.03-3μM dose-dependently inhibited IGF-1- or insulin-induced autophosphorylation of IGF-1R, as well as the downstream signaling, including phosphorylation of ATK, IRS-1 and ERK. And this inhibition on phosphorylation on IGF-1R and its downstream can be also observed in vivo. In COLO 205, MCF-7, and NCI-H929 cells treated with GSK1904529A ranging in 0.3-10μM for 24h or 48h, dose-dependent increased accumulation in G1 of the cell cycle could be observed. GSK1904529A showed anti-proliferation of cell lines derived from solid and hematologic malignancies, among which multiple myeloma and Ewing’s sarcoma cell lines showed most sensitivity. Oral administration of GSK1904529A at 30mg/kg once daily or twice daily for 21 days significantly inhibited tumor growth inhibition of female nude mice bearing tumor xenografts of NIH-3T3/LISN, COLO 205, HT29 and BxPC3, respectively. As GSK1904529A is also a IR inhibitor, minimal effects on blood glucose levels can be observed in animals treated with a single dose of 30 mg/kg GSK1904529A[1].
作用机制 GSK1904529A is a reversible, ATP-competitive inhibitor.[1]

GSK1904529A 细胞研究

细胞系 浓度 检测类型 检测时间 活动说明 数据源
human COLO205 cells Proliferation assay 72 h Antiproliferative activity against human COLO205 cells after 72 hrs by Celltiter assay, IC50=124 nM 19101143
human LP-1 cells Proliferation assay 72 h Antiproliferative activity against human LP-1 cells after 72 hrs by Celltiter assay, IC50=104 nM 19101143
human NCI-H929 cells Proliferation assay 72 h Antiproliferative activity against human NCI-H929 cells after 72 hrs by Celltiter assay, IC50=81 nM 19101143
human SK-ES cells Proliferation assay 72 h Antiproliferative activity against human SK-ES cells after 72 hrs by Celltiter assay, IC50=61 nM 19101143

GSK1904529A 动物研究

Dose Mice: 30 mg/kg[1] (p.o.)
Administration p.o.

GSK1904529A 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.17mL

0.23mL

0.12mL

5.87mL

1.17mL

0.59mL

11.74mL

2.35mL

1.17mL

GSK1904529A 技术信息

CAS号1089283-49-7
分子式C44H47F2N9O5S
分子量 851.963
别名 GSK 4529
运输蓝冰
存储条件

液体 -20°C:3-6个月-80°C:12个月

粉末 Sealed in dry,Store in freezer, under -20°C

溶解度

DMSO: 50 mg/mL(58.69 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

动物实验配方
Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。